The US Food and Drug Administration (FDA) has approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) in combination with oxaliplatin, fluorouracil, and leucovorin for the first-line ...

Please provide your email address to receive an email when new articles are posted on . Irinotecan liposome injection combined with 5-FU/leucovorin and oxaliplatin prolonged OS compared with ...

PURPOSE: To estimate the toxicity and response rate of high-dose liposome-encapsulated doxorubicin (TLC D-99, Evacet, The Liposome Company Inc, Princeton, NJ) in patients with advanced breast cancer.

A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects. Background: Schedules with ...

Please provide your email address to receive an email when new articles are posted on . In a video interview with Healio, Cecilia Monge, MD, MPH, FACP, from the NCI Center for Cancer Research at NIH, ...

Sumitomo Pharma America, Inc. (SMPA) today announced clinical data from its ongoing first-in-human Phase 1/2 trial of SMP-3124LP (NCT06526819). SMP-3124LP is a structurally distinct, investigational, ...

PARIS--(BUSINESS WIRE)-- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the United States Food and Drug Administration (FDA) has granted the company Fast Track designation for ...

Photodynamic therapy (PDT) uses light to activate special drugs called photosensitizers to destroy cancer cells with high precision. The basic principle behind PDT is the interaction between light, a ...

At the 30th Annual Congress of the European Society for Gene and Cell Therapy in Brussels this week, researchers presented both preclinical and clinical ...